Immunovant, Inc. Quarterly Return On Assets in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Immunovant, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q2 2024.
  • Immunovant, Inc. Return On Assets for the quarter ending June 30, 2024 was -48.3 %, a 19% increase year-over-year.
  • Immunovant, Inc. annual Return On Assets for 2023 was -59.3 %, a 41.5% decline from 2022.
  • Immunovant, Inc. annual Return On Assets for 2022 was -41.9 %, a 6.26% decline from 2021.
  • Immunovant, Inc. annual Return On Assets for 2021 was -39.4 %, a 56.8% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -48.3 +11.3 +19% Apr 1, 2024 Jun 30, 2024
Q1 2024 -51.3 -3.08 -6.38% Jan 1, 2024 Mar 31, 2024
Q4 2023 -55.3 -12.6 -29.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -67.8 -31.5 -86.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -59.6 -27.6 -86.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -48.3 -17.1 -55% Jan 1, 2023 Mar 31, 2023
Q4 2022 -42.8 -13.9 -48.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -36.4 -7.9 -27.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -32 -5.62 -21.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -31.1 -4.1 -15.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -28.8 +2.2 +7.09% Oct 1, 2021 Dec 31, 2021
Q3 2021 -28.5 +3.91 +12.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -26.4 +19 +41.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -27 +29.3 +52% Jan 1, 2021 Mar 31, 2021
Q4 2020 -31 +17.8 +36.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -32.4 -5.84 -22% Jul 1, 2020 Sep 30, 2020
Q2 2020 -45.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 -56.4 Jan 1, 2020 Mar 31, 2020
Q4 2019 -48.8 Oct 1, 2019 Dec 31, 2019
Q3 2019 -26.5 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.